Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Sclerosis · Multiple Sclerosis Fatigue

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Mahsa Ghajarzadeh, MD, PhD) · mghajar2@jhmi.edu · 410-614-1522
Contact: Study coordinator (Lauren Vega, BSN) · Ldimarc2@jhmi.edu · 410-614-1522

Study leads

Bardia Nourbakhsh, MD
Principal Investigator
Johns Hopkins School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cannabis as a Complementary Treatment in Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Montreal, Canada

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE4

New Haven, United States · Washington D.C., United States

Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis

Multiple Sclerosis · Insomnia

Abroad (travel likely)RecruitingPHASE2

Kansas City, United States

Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Taichung, Taiwan